Protillion Biosciences Closes $18M Series A Round
Biotech firm Protillion Biosciences has closed an $18 million Series A financing round funded by Arch Venture Partners and Illumina Ventures.
News
listing-news
Latest News
Company Spotlight – Alamar
“While most liquid biopsy efforts focus on circulating tumor DNA (ctDNA), Alamar is taking a different path, looking for circulating cancer-associated protein biomarkers,” said Nick Naclerio, Ph.D., Founding Partner of Illumina Ventures. “This is mostly undiscovered territory and could ultimately lead to highly sensitive diagnostics that find cancer and other diseases early when they are most ...
Genomeweb: Stilla Technologies Raises €31.3M In Financing
Stilla Technologies announced on Tuesday it has raised €31.3 million ($35.2 million) in new funding. The Paris-based firm will use the funds to expand its global commercial presence and develop its next-generation digital PCR platform.
Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing
Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the completion of an oversubscribed and up-sized $215 million Series B financing. Including this round, the Company has raised over $300 million to date.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
0 selected
Generating previews...